Genetic and antigenic analysis of epidemic influenza viruses isolated during 2006-2007 season in Taiwan

Journal of Medical Virology

Volumn 80, Issue 2, 2008, Pages 316-322

  Lin, Jih Hui ^a   Chiu, Shu Chun ^a   Lee, Cheng Hao ^a   Su, Yung Jui ^a   Tsai, Han Chuan ^a   Peng, Yen Tzu ^a   Wu, Ho Seng ^a  

^a CENTER FOR DISEASE CONTROL   (Taiwan)

Author keywords

Influenza virus; Phylogenetic analysis; Surveillance; Taiwan

Indexed keywords

ADAMANTANE; VIRUS RNA;

ANIMAL CELL; ANTIGENICITY; ARTICLE; CLINICAL LABORATORY; EPIDEMIC; GENETIC ANALYSIS; GENOTYPE; HUMAN; INFLUENZA; INFLUENZA VIRUS; INFLUENZA VIRUS A; INFLUENZA VIRUS B; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TAIWAN; VIRUS ISOLATION; VIRUS RESISTANCE;

AMANTADINE; ANTIGENS, VIRAL; ANTIVIRAL AGENTS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA B VIRUS; INFLUENZA, HUMAN; ORTHOMYXOVIRIDAE; TAIWAN;

CERCOPITHECINE HERPESVIRUS 1; INFLUENZA B VIRUS; MUSTELA; ORTHOMYXOVIRIDAE;

EID: 37549037517     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21074     Document Type: Article

References (26)

1. Bright RA, Medina MJ, Xu X, Perez-Oronoz G, Wallis TR, Davis XM, Povinelli L, Cox NJ, Klimov AI. 2005. Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: A cause for concern. Lancet 366:1175-1181.
2. Caton AJ, Brownlee GG, Yewdell JW, Gerhard W. 1982. The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype). Cell 31:417-427.
3. Daum LT, Canas LC, Smith CB, Klimov A, Huff W, Barnes W, Lohman KL. 2002. Genetic and antigenic analysis of the first A/New Caledonia/20/99-like H1N1 influenza isolates reported in the Americas. Emerg Infect Dis 8:408-412.
4. Daum LT, Shaw MW, Klimov AI, Canas LC, Macias EA, Niemeyer D, Chambers JP, Renthal R, Shrestha SK, Acharya RP, Huzdar SP, Rimal N, Myint KS, Gould P. 2005. Influenza A (H3N2) outbreak, Nepal. Emerg Infect Dis 11:1186-1191.
5. Hatakeyama S, Sugaya N, Ito M, Yamazaki M, Ichikawa M, Kimura K, Kiso M, Shimizu H, Kawakami C, Koike K, Mitamura K, Kawaoka Y. 2007. Emergence of influenza B viruses with reduced sensitivity to neuraminidase inhibitors. JAMA 297:1435-1442.
6. Hay AJ, Gregory V, Douglas AR, Lin YP. 2001. The evolution of human influenza viruses. Philos Trans R Soc Lond B Biol Sci 356:1861-1870.
7. Li W, Escarpe PA, Eisenberg EJ, Cundy KC, Sweet C, Jakeman KJ, Merson J, Lew W, Williams M, Zhang L, Kim CU, Bischofberger N, Chen MS, Mendel DB. 1998. Identification of GS 4104 as an orally bioavailable prodrug of the influenza virus neuraminidase inhibitor GS 4071. Antimicrob Agents Chemother 42:647-653.
8. Lin JH, Chiu SC, Su IR, Chen HY. 2004. Isolation of influenza viruses and influenza epidemics in Taiwan area, 1999-2002. In: Kawaoka Y, editor. Options for the control of influenza V. Amsterdam: Elsevier Science. pp 430-434.
9. Lin JH, Chiu SC, Shaw MW, Lin YC, Lee CH, Chen HY, Klimov A. 2007. Characterization of the epidemic influenza B viruses isolated during 2004-2005 season in Taiwan. Virus Res 124:204-211.
10. Lindstrom SE, Hiromoto Y, Nishimura H, Saito T, Nerome R, Nerome K. 1999. Comparative analysis of evolutionary mechanisms of the hemagglutinin and three internal protein genes of influenza B virus: Multiple cocirculating lineages and frequent reassortment of the NP, M, and NS genes. J Virol 73:4413-4426.
11. McCullers JA, Wang GC, He S, Webster RG. 1999. Reassortment and insertion-deletion are strategies for the evolution of influenza B viruses in nature. J Virol 73:7343-7348.
12. Muyanga J, Matsuzaki Y, Sugawara K, Kimura K, Mizuta K, Ndumba I, Muraki Y, Tsuchiya E, Hongo S, Kasolo FC, Numazaki Y, Nakamura K. 2001. Antigenic and genetic analyses of influenza B viruses isolated in Lusaka, Zambia in 1999. Arch Virol 146:1667-1679.
13. Nakajima K, Nobusawa E, Tonegawa K, Nakajima S. 2003. Restriction of amino acid change in influenza A virus H3HA: Comparison of amino acid changes observed in nature and in vitro. J Virol 77:10088-10098.
14. Ohuchi M, Asaoka N, Sakai T, Ohuchi R. 2006. Roles of neuraminidase in the initial stage of influenza virus infection. Microbes Infect 8:1287-1293.
15. Raymond FL, Caton AJ, Cox NJ, Kendal AP, Brownlee GG. 1986. The antigenicity and evolution of influenza H1 haemagglutinin, from 1950-1957 and 1977-1983: Two pathways from one gene. Virology 148:275-287.
16. Shaw MW, Xu X, Li Y, Normand S, Ueki RT, Kunimoto GY, Hall H, Klimov A, Cox NJ, Subbarao K. 2002. Reappearance and global spread of variants of influenza B/Victoria/2/87 lineage viruses in the 2000-2001 and 2001-2002 seasons. Virology 303:1-8.
17. Townsend MB, Dawson ED, Mehlmann M, Smagala JA, Dankbar DM, Moore CL, Smith CB, Cox NJ, Kuchta RD, Rowlen KL. 2006. Experimental evaluation of the FluChip diagnostic microarray for influenza virus surveillance. J Clin Microbiol 44:2863-2871.
18. Tseng RK, Chen HY, Hong CB. 1996. Influenza virus infections in Taiwan from 1979 to 1995. Jpn J Med Sci Biol 49:77-93.
19. von Itzstein M, Wu WY, Kok GB, Pegg MS, Dyason JC, Jin B, Van Phan T, Smythe ML, White HF, Oliver SW, Colman PM, Varghese JN, Ryan DM, Woods JM, Bethell RC, Hotham VJ, Cameron JM, Penn CR. 1993. Rational design of potent sialidase-based inhibitors of influenza virus replication. Nature 363:418-423.
20. Wentworth DE, Thompson BL, Xu X, Regnery HL, Cooley AJ, McGregor MW, Cox NJ, Hinshaw VS. 1994. An influenza A (HlNl) virus, closely related to swine influenza virus, responsible for a fatal case of human influenza. J Virol 68:2051-2058.
21. WHO. 2006. Epidemiology of WHO-confirmed human cases of avian influenza A (H5N1) infection. Wkly Epidemiol Rec 81:249-257.
22. WHO. 2007. Recommended composition of influenza virus vaccines for use in the 2007-2008 influenza season. Wkly Epidemiol Rec 82:69-74.
23. Wiley DC, Skehel JJ. 1987. The structure and function of the hemagglutinin membrane glycoprotein of influenza virus. Annu Rev Biochem 56:365-394.
24. Wiley DC, Wilson IA, Skehel JJ. 1981. Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation. Nature 289:373-378.
25. Wilson IA, Cox NJ. 1990. Structural basis of immune recognition of influenza virus hemagglutinin. Annu Rev Immunol 8:737-771.
26. Xu X, Lindstrom SE, Shaw MW, Smith CB, Hall HE, Mungall BA, Subbarao K, Cox NJ, Klimov A. 2004. Reassortment and evolution of current human influenza A and B viruses. Virus Res 103:55-60.